Sensus Healthcare CEO Shares A Look Into Skin Cancer Treatment
Sensus Healthcare Inc (NASDAQ: SRTS) (NASDAQ: SRTSU) is micro-cap manufacturer of superficial radiation therapy (SRT) devices for the treatment of skin cancer and keloids, which went public on the Nasdaq exchange in June. Benzinga recently had the chance to chat with the company’s CEO Joseph C. Sardano, who shared some insight into the company and […]
Do You Have a Keloid Scar?
If you have a scar that doesn’t seem to be fading, or even appears to be growing in size, it is important to determine whether that scar is a keloid or not. There are two types of raised scars: keloid and hypertrophic. While both hypertrophic scars and keloid scars themselves are benign, the uncontrolled growth […]
Sensus Healthcare Receives the BioFlorida Company of the Year Award
BOCA RATON, Fla., Dec. 13, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today that it has been named the winner of the BioFlorida Company of the Year Award at […]
